Suzhou GenePharma Co., Ltd.
PrivateLast Round
Private Equity
Feb 7, 2024
Est. Valuation
$124.74M
Total Funding Raised
$7.88M
Company Overview
Suzhou GenePharma Co., Ltd. is a biotechnology company that researches, develops, and manufactures RNA-based technologies, including siRNA, miRNA, and CRISPR products, as well as providing oligonucleotide research and development services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou GenePharma Co., Ltd. Comparables
Compare Suzhou GenePharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Tsingke Biotech Co., Ltd. | 81% | |
| SIRION Biotech | 77% | |
| BBI Life Sciences Corporation | 75% | |
Suzhou GenePharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 7, 2024 | ||||
| Private Equity | Jul 19, 2021 | ||||
| Private Equity | Aug 17, 2017 | ||||
| Private Equity | Feb 18, 2016 | ||||
| Angel | Feb 1, 2008 |
Key People
Founding team and executive leadership
Suzhou GenePharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Angel |
| Guosen Securities | Private Equity |
| Guoxin Securities Co., Ltd. | Private Equity |
| 华融瑞泽投资管理有限公司 | Private Equity |
| Suzhou Industrial Park Venture Capital Guidance Fund | Private Equity |
| Everbright Securities Company | Private Equity |
| Zhongtai Securities | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2025
Grew 144% QoQ, from 18 to 44 employees.
- Feb 7, 2024
$3.54M round raised
Suzhou GenePharma Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Suzhou GenePharma Co., Ltd.'s valuation, stock price, and market status.